For patients in need of extracorporeal life support in critical care units, CardiacAssist (Pittsburgh, PA) won FDA clearance to introduce its TandemLung oxygenator, a device that can perform blood oxygenation and efficient CO2 removal. It’s been designed to improve the simplicity and speed of using blood oxygenation technology and make it more accessible, allowing more hospitals to use it for treating acute cardiac and respiratory cases. The CardiacAssist company already makes available its TandemHeart blood pump for critically ill patients that can be paired with the new oxygenator.
The main advantages of the TandemLung are its low priming volume and patented radial flow technology, which allow the initiation of oxygenation faster than with similar system.
“After our original TandemHeart pump was cleared for use with an oxygenator in 2011, our team immediately began working with experts in the field to understand how to reduce the complexity of cardiopulmonary bypass technology so that more patients could receive this potentially life-saving procedure,” said John Marous, President and CEO of CardiacAssist. “The design of the TandemLung is a direct result of those efforts. This release represents our 6th new product clearance since September 2013, and we are proud to dedicate ourselves to improving the lives of patients by delivering innovative, easy-to-use devices for simplified life support.”